Literature DB >> 33760183

NUPR1 and its potential role in cancer and pathological conditions (Review).

Tracey A Martin1, Amber Xinyu Li1, Andrew J Sanders1, Lin Ye1, Kathryn Frewer1, Rachel Hargest1, Wen G Jiang1.   

Abstract

Nuclear protein‑1 (NUPR1) is also known as Com‑1 or p8. It is a protein primarily found in the nucleus of various cells, including cancer cells, and it has been found to play an important role in cell stress and stress‑related apoptosis. Over the past two decades, NUPR1 has been firmly indicated to play a role in the development and progression of numerous types of cancer, as well as in a number of other pathological conditions, including pancreatitis, diabetes, neurological and inflammatory conditions. The past decade has witnessed a rapid understanding of the biological and cellular mechanisms through which NUPR1 operates on cells and the identification of new variant of the protein. Most importantly, there have been comprehensive studies on the clinical and pathological aspects of NUPR1 and its variant in multiple malignancies and identification of therapeutic methods by targeting the protein. The present review aimed to summarise the current knowledge relating to NUPR1 in human malignancies and to discuss the associated controversies and potential future prospects of this molecule.

Entities:  

Keywords:  NUPR1, Com‑1, p8, NUPR1‑like, cancer, NUPR2, metastasis, survival, therapeutics

Year:  2021        PMID: 33760183     DOI: 10.3892/ijo.2021.5201

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

1.  Transcriptomic Profiling of Gene Expression Associated with Granulosa Cell Tumor Development in a Mouse Model.

Authors:  Nan Ni; Xin Fang; Destiny A Mullens; James J Cai; Ivan Ivanov; Laurent Bartholin; Qinglei Li
Journal:  Cancers (Basel)       Date:  2022-04-27       Impact factor: 6.575

Review 2.  Targeting the Integrated Stress Response in Cancer Therapy.

Authors:  Xiaobing Tian; Shengliang Zhang; Lanlan Zhou; Attila A Seyhan; Liz Hernandez Borrero; Yiqun Zhang; Wafik S El-Deiry
Journal:  Front Pharmacol       Date:  2021-09-24       Impact factor: 5.810

3.  NUPR1 promotes the proliferation and metastasis of oral squamous cell carcinoma cells by activating TFE3-dependent autophagy.

Authors:  Tengfei Fan; Xiaoning Wang; Sheng Zhang; Ping Deng; Yi Jiang; Yidan Liang; Sheng Jie; Qing Wang; Chuwen Li; Guocai Tian; Zhen Zhang; Zhenhu Ren; Bo Li; Yanrong Chen; Zhijing He; Yan Luo; Mingliang Chen; Hanjiang Wu; Zhengping Yu; Huifeng Pi; Zhou Zhou; Zhiyuan Zhang
Journal:  Signal Transduct Target Ther       Date:  2022-04-25

Review 4.  Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression.

Authors:  James A McCubrey; Li V Yang; Stephen L Abrams; Linda S Steelman; Matilde Y Follo; Lucio Cocco; Stefano Ratti; Alberto M Martelli; Giuseppa Augello; Melchiorre Cervello
Journal:  Cells       Date:  2022-07-09       Impact factor: 7.666

5.  Development and validation of a prognosis prediction model based on 18 endoplasmic reticulum stress-related genes for patients with lung adenocarcinoma.

Authors:  Long Shu; Shuang Liu; Yongguang Tao
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

Review 6.  Targeting Protein Degradation Pathways in Tumors: Focusing on their Role in Hematological Malignancies.

Authors:  Anna Wolska-Washer; Piotr Smolewski
Journal:  Cancers (Basel)       Date:  2022-08-03       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.